Phibro Animal Health Corporation
Phibro Animal Health Corporation (PAHC) Revenue
Annual & quarterly revenue history · segment & region breakdown
PAHC · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsPhibro Animal Health Corporation trailing twelve-month (TTM) revenue is $1.50B, an increase of 27.37% year-over-year from $1.30B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $1.30B | +$0.28B | +27.37% |
| 2024-06-30 | $1.02B | +$0.04B | +4.07% |
| 2023-06-30 | $0.98B | +$0.04B | +3.78% |
| 2022-06-30 | $0.94B | +$0.11B | +13.07% |
| 2021-06-30 | $0.83B | +$0.03B | +4.12% |
| 2020-06-30 | $0.80B | -$0.03B | -3.34% |
| 2019-06-30 | $0.83B | +$0.01B | +0.98% |
| 2018-06-30 | $0.82B | +$0.06B | +7.29% |
| 2017-06-30 | $0.76B | +$0.01B | +1.70% |
| 2016-06-30 | $0.75B | +$0.00B | +0.39% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare PAHC revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Phibro Animal Health Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Phibro Animal Health Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Phibro Animal Health Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PAHC revenue · 4 questionsPAHC's trailing twelve-month (TTM) revenue is $1.50B. That is an increase of 27.37% year-over-year from $1.30B in FY2025.
▸ Source: FMP · Phibro Animal Health Corporation SEC filings · GAAP · Phibro Animal Health Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026